Endoscopic management of ureteral calculus in a patient with ureterosigmoidostomy diversion.

Lithiasis after urinary diversion is an uncommon condition that poses therapeutic challenges. The authors report the case of a patient submitted to cystectomy and ureterosigmoidostomy 35 years ago due to bladder endometriosis. The patient presented with a ureteral stone and was treated by retrograde endoscopic extraction.

Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients.

Mutations located in the 109-amino acid fragment of NS5B are typically associated with resistance to interferon (IFN) and ribavirin (RIB) and to new antiviral drugs. The prevalence of these mutations was examined in 69 drug-naïve individuals with hepatitis C virus (HCV) infections in Rio de Janeiro, Brazil. Mutations related to non-response to IFN/RIB were observed in all subtypes studied (1a, 1b, 2b, 3a and 4). The most common mutation was Q309R, present in all subtypes, except subtype 2b with frequency above 20%. D244N was detected only in subtype 3a and A333E was detected only in subtype 2b. We did not detect the S282T, S326G or T329I mutations in any of the samples analysed. Of note, the C316N mutation, previously related to a new non-nucleoside compound (HCV796 and AG-021541), was observed in only eight of 33 (24%) samples from subtype 1b. Site 316 was under positive selection in this HCV variant. Our data highlight the presence of previously described resistance mutations in HCV genotypes from drug-naïve patients.

Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients.

OBJECTIVE: To evaluate the capability of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) to assess steatohepatitis and fibrosis determined by histopathology in type 2 diabetic patients. METHODS: Fifty-nine type 2 diabetic patients (49 women, 10 men; mean age, 54 ± 9 years) were submitted to liver biopsy for the evaluation of non-alcoholic fatty liver disease (NAFLD) and underwent DWI on a 3.0T MR system using 10 b values. Institutional approval and patient consent were obtained. Pure molecular-based (D), perfusion-related (D*), and vascular fraction (f) were calculated using a double exponential model and least squares curve fitting. D, D*, and f were compared between patients with and without steatohepatitis and between patients with and without fibrosis. The variables were compared by using the Ranksum test and Student t-test. RESULTS: Steatohepatitis was observed in 22 patients and fibrosis in 16 patients. A lower D median (0.70 s/mm2 vs. 0.83 s/mm2, p<0.05) and a lower D* median (34.39 s/mm2 vs. 45.23 s/mm2, p<0.05) were observed among those with steatohepatitis. A lower D median (0.70 s/mm2 vs. 0.82 s/mm2, p<0.05) and a lower D* median (35.01 s/mm2 vs. 44.76 s/mm2, p=0.05) were also observed among those with fibrosis. CONCLUSION: IVIM-DWI has the potential to aid in the characterization of steatohepatitis and fibrosis.

Low bone mineral density in noncholestatic liver cirrhosis: prevalence, severity and prediction.

BACKGROUND: Metabolic bone disease has long been associated with cholestatic disorders. However, data in noncholestatic cirrhosis are relatively scant. AIMS: To determine prevalence and severity of low bone mineral density in noncholestatic cirrhosis and to investigate whether age, gender, etiology, severity of underlying liver disease, and/or laboratory tests are predictive of the diagnosis. PATIENTS/METHODS: Between March and September/1998, 89 patients with noncholestatic cirrhosis and 20 healthy controls were enrolled in a cross-sectional study. All subjects underwent standard laboratory tests and bone densitometry at lumbar spine and femoral neck by dual X-ray absorptiometry. RESULTS: Bone mass was significantly reduced at both sites in patients compared to controls. The prevalence of low bone mineral density in noncholestatic cirrhosis, defined by the World Health Organization criteria, was 78% at lumbar spine and 71% at femoral neck. Bone density significantly decreased with age at both sites, especially in patients older than 50 years. Bone density was significantly lower in post-menopausal women patients compared to pre-menopausal and men at both sites. There was no significant difference in bone mineral density among noncholestatic etiologies. Lumbar spine bone density significantly decreased with the progression of liver dysfunction. No biochemical variable was significantly associated with low bone mineral density. CONCLUSIONS: Low bone mineral density is highly prevalent in patients with noncholestatic cirrhosis. Older patients, post-menopausal women and patients with severe hepatic dysfunction experienced more advanced bone disease. The laboratory tests routinely determined in patients with liver disease did not reliably predict low bone mineral density.

Endoscopic management of ureteral calculus in a patient with ureterosigmoidostomy diversion

Lithiasis after urinary diversion is an uncommon condition that poses therapeutic challenges. The authors report the case of a patient submitted to cystectomy and ureterosigmoidostomy 35 years ago due to bladder endometriosis. The patient presented with a ureteral stone and was treated by retrograde endoscopic extraction.

Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients

Mutations located in the 109-amino acid fragment of NS5B are typically associated with resistance to interferon (IFN) and ribavirin (RIB) and to new antiviral drugs. The prevalence of these mutations was examined in 69 drug-naïve individuals with hepatitis C virus (HCV) infections in Rio de Janeiro, Brazil. Mutations related to non-response to IFN/RIB were observed in all subtypes studied (1a, 1b, 2b, 3a and 4). The most common mutation was Q309R, present in all subtypes, except subtype 2b with frequency above 20 percent. D244N was detected only in subtype 3a and A333E was detected only in subtype 2b. We did not detect the S282T, S326G or T329I mutations in any of the samples analysed. Of note, the C316N mutation, previously related to a new non-nucleoside compound (HCV796 and AG-021541), was observed in only eight of 33 (24 percent) samples from subtype 1b. Site 316 was under positive selection in this HCV variant. Our data highlight the presence of previously described resistance mutations in HCV genotypes from drug-naïve patients.

Effect of liver cirrhosis on body composition: evidence of significant depletion even in mild disease.

BACKGROUND AND AIMS: Malnutrition is common in liver cirrhosis patients. However, it is under-diagnosed because liver disease affects the traditional nutritional assessment. An understanding of changes in body composition and the establishment of the tissue-loss pattern in liver cirrhosis patients could help practitioners to better manage malnutrition in this setting. The aims of this study were: to quantify body composition changes, to determine tissue loss pattern, and to assess the relation of these to the severity of hepatic dysfunction. METHODS: Seventy-nine patients and 17 controls were studied. Total body water and extracellular water were measured using dilution techniques. Intracellular water and body cell mass were calculated from these parameters. Total body fat was obtained using absorptiometry. RESULTS: Extracellular water was increased and intracellular water was decreased in patients. The two major compartments (body cell mass and body fat) were significantly reduced, mainly in patients with moderate and severe disease. However, significant losses occurred even in Child-Pugh class A patients. We established a tissue-loss pattern. In Child-Pugh class A patients body fat loss predominated. Child-Pugh class B patients had losses in at least one of the two compartments. Most Child-Pugh class C patients had simultaneous depletion in both compartments. CONCLUSIONS: Liver cirrhosis was characterized by a significant reduction in body cell mass and body fat and by a redistribution of body water. Significant losses occurred even in patients with mild disease. There was a more pronounced loss of fat in the initial stages, followed by an accelerated loss of body cell mass in the advanced stages of liver cirrhosis.

Low bone mineral density in noncholestatic liver cirrhosis: prevalence, severity and prediction

RACIONAL: Existe associação entre doença óssea metabólica e doença hepática colestática. Contudo, a associação com cirrose não-colestática ainda é pouco conhecida. OBJETIVOS: Determinar a prevalência e a gravidade da perda de densidade mineral óssea na cirrose não-colestática e investigar fatores preditivos do seu diagnóstico. MÉTODOS: Oitenta e nove pacientes e 20 controles foram estudados de março a setembro de 1998. Todos foram submetidos a exames laboratoriais e densitometria óssea da coluna lombar e do colo do fêmur. RESULTADOS: A massa óssea estava significativamente reduzida em ambos os sítios nos pacientes quando comparado aos controles. A prevalência da perda de massa óssea na cirrose não-colestática, de acordo com os critérios da Organização Mundial da Saúde, foi de 78 por cento na coluna lombar e 71 por cento no colo do fêmur. A massa óssea diminuiu significativamente com a idade em ambos os sítios, especialmente em pacientes acima de 50 anos. Pacientes mulheres pós-menopausa tinham massa óssea significativamente menor do que pacientes mulheres pré-menopausa e homens em ambos os sítios. Não houve diferença significativa na massa óssea entre as etiologias não-colestáticas. A massa óssea da coluna lombar diminuiu significativamente com a progressão da disfunção hepática. Nenhuma variável bioquímica foi associada com a perda da massa óssea. CONCLUSÕES: A perda de massa óssea foi freqüente em pacientes com cirrose não-colestática. Pacientes idosos, do sexo feminino na pós-menopausa e com disfunção hepática grave apresentaram doença óssea mais avançada. Os exames laboratoriais rotineiramente dosados nos pacientes com doença hepática não puderam predizer com segurança a presença de redução na massa óssea.

Peritonite bacteriana espontânea na cirrose hepática / Spontaneous bacterial peritonitis in liver cirrhosis

PBE é complicaçäo freqüente e potencialmente fatal da cirrose hepática, com prevalência em torno de 20 por cento. É provavelmente, conseqüência da colonizaçao do LA suscetível por episódios de bacteremia prolongados, ambos decorrentes da disfunçäo imune presentes na cirrose hepática. Uma pancreatese diagnóstica deve ser realizada em qualquer paciente cirrótico com sintomas compatíveis com PBE, mesmo que frustos. O método otimizado, através da inoculaçäo de frascos de hemocultura com LA, aumentou a sensibilidade da cultura. Os microrganismos mais freqüentemente isolados säo os bastonetes gram-negativos. Contagem de PMN ò 250/mm3 é indicativa de PBE, devendo ser iniciado o tratamento com cefalosporinas de terceira geraçäo. A mortalidade dessa entidade é alta e está relacionada à gravidade da doença hepática.

Comparaçäo entre dois modelos de avaliaçäo do estado nutricional na cirrose hepática: tradicional e multicomportamental / Comparison brtween two models of nutritional status analysis in liver cirrhosis: traditional and multicompartimental

Apesar de estar intimamente associada à doença hepática crônica e representar um fator de risco para morbi/mortalidade, a desnutrição proteico-calórica (DPC) é freqüentemente subdiagnosticada, pois as técnicas tradicionais de avaliação nutricional possuem inúmeras limitações quando utilizadas nestes pacientes. O objetivo deste estudo foi avaliar o estado nutricional em pacientes com cirrose, através de dois modelos de estudo da composição corporal, comparando com controles. O modelo tradicional utilizou a Avaliação Global Subjetiva, a antropometria e testes bioquímicas, dividindo a massa corporal em massa de gordura e massa sem gordura. No modelo multicompartimental, quatro compartimentos (água extracelular, massa celular, gordura corporal e mineral corporal) foram medidos, através da absortometda e da técnica de diluição do deutério corrigida pelo brometo. Esta metodologia foi aplicada a 79 pacientes e 17 controles. As principais mudanças na composição corporal dos pacientes com cirrose foram aumento da água extracelular e diminuição da massa celular e da gordura corporal. Estas alterações aumentaram com o agravamento da doença hepática e foram independentes da etiologia. A perda de gordura predominou nos estágios iniciais e foi seguida pela perda de massa celular nos estágios mais avançados da doença hepática. DPC foi mais freqüente e grave no modelo multicompartimental, especialmente nos pacientes Child A e B. Embora alguns parâmetros antropométricos tenham se correlacionado com massa celular e gordura corporal, nenhum modelo obtido por regressão linear foi suficientemente preciso para detectar pequenas variações nestes compartimentos do mesmo indivíduo. A prevalência, a gravidade e as características da DPC foram dependentes da classificação funcional da doença hepática e do modelo de avaliação nutricional utilizado. O modelo multicompartimental proporcionou uma avaliação mais precisa da DPC na cirrose, fornecendo dados que auxiliarão no entendimento da sua fisiopatologia e no planejamento do suporte nutricional destes pacientes